SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-009574
Filing Date
2019-03-27
Accepted
2019-03-27 16:01:25
Documents
5
Period of Report
2019-05-08
Effectiveness Date
2019-03-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A torc-def14a_20190508.htm DEF 14A 656168
2 GRAPHIC gfmu0zm03k3z000002.jpg GRAPHIC 5893
3 GRAPHIC gfmu0zm03k3z000001.jpg GRAPHIC 5658
4 GRAPHIC gfmu0zm03k3z000003.jpg GRAPHIC 58804
5 GRAPHIC gfmu0zm03k3z000004.jpg GRAPHIC 56619
  Complete submission text file 0001564590-19-009574.txt   832631
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 19708408
SIC: 2834 Pharmaceutical Preparations